MONTVALE, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that it has entered into...
MONTVALE, N.J., Jan. 28 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that, following a review...
MONTVALE, N.J., Jan. 12 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) has completed enrollment of its...
Company Expects Its Common Stock to Remain Listed While it Engages in Compliance Process MONTVALE, N.J., Dec. 24 /PRNewswire-FirstCall/...
Synvista Therapeutics Technology Provided CML Biomarker Data for Studies MONTVALE, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Synvista...
MONTVALE, N.J., Dec. 15 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) has dosed the first patient in a...
S.Y. Bancorp, Inc. Announced Quarterly Dividend LOUISVILLE, Ky., Feb. 20 /PRNewswire-FirstCall/ -- On Tuesday, February 17, 2004, the Board of...
RNS Number:0170U Systems Integrated Research PLC 08 January 2004 SiRViS IT plc ("the Company") (formerly Systems Integrated Research plc...
RNS Number:3107T AIM 16 December 2003 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2...
RNS Number:1848T Systems Integrated Research PLC 12 December 2003 Systems Integrated Research plc 12 December 2003 Systems...
RNS Number:1847T Systems Integrated Research PLC 11 December 2003 Systems Integrated Research plc (the "Company") Change on Directorship...
RNS Number:3223R Systems Integrated Research PLC 27 October 2003 Systems Integrated Research plc (the "Company") Appointment of...
RNS Number:3510Q Systems Integrated Research PLC 30 September 2003 Systems Integrated Research plc Results of Annual General Meeting...
RNS Number:5736O Systems Integrated Research PLC 12 August 2003 Systems Integrated Research plc Preliminary Results year ended 31 May...
Support
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads